NCT05257083 · Interventional trial
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
Overall registry status Active not recruiting
Phase 3
Conditions Multiple Myeloma
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory